Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1999;19:2431-2438

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hahnel, D.
Right arrow Articles by Engelmann, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hahnel, D.
Right arrow Articles by Engelmann, B.
Related Collections
Right arrow Lipid and lipoprotein metabolism
Right arrow Oxidant stress
Right arrow Pathophysiology
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1999;19:2431-2438.)
© 1999 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Role of Plasmalogens in the Enhanced Resistance of LDL to Copper-Induced Oxidation After LDL Apheresis

Daniela Hahnel; Joachim Thiery; Thorolf Brosche; Bernd Engelmann

From the Physiologisches Institut der Universität München (D.H., B.E.) and the Institut für Klinische Chemie, Klinikum Grosshadern, Universität München (J.T.), Munich, and the Institut für Gerontologie, Universität Erlangen-Nürnberg (T.B.), Nürnberg, Germany.

Correspondence to Dr Bernd Engelmann, Physiologisches Institut der Universität München, Schillershr. 44, D-80336, Munich, Germany. E-mail Bernd.Engelmann{at}physiol.med.uni-muenchen.de

Abstract—Extracorporeal reduction of plasma low density lipoproteins (LDLs) by LDL apheresis was shown to attenuate the proatherogenic influences of LDL, such as impairment of vasodilation and increased monocyte adhesion to the endothelium. In 16 patients with familial hypercholesterolemia, we analyzed whether LDL apheresis by the heparin precipitation procedure affected the oxidative resistance of LDL. Plasma LDL cholesterol concentrations were reduced by 65% after the apheresis. The lag time of copper-mediated LDL oxidation was increased from 103 to 117 minutes (P<0.0005). The LDL contents of {alpha}-tocopherol and ß-carotene, as well as the ratio of monounsaturated to polyunsaturated fatty acids in LDL, were not altered. However, the LDL apheresis induced a 15% increase in the LDL contents of plasmalogen phospholipids (P<0.0005), a class of ether phospholipids that were recently shown to prevent lipid oxidation. The phosphatidylcholine (PC) to lysoPC ratio was elevated by 16% after the apheresis (P<0.0005). The percent increase in LDL plasmalogen phospholipids showed a close association with the increased lag time after apheresis (P<0.0005). The LDL plasmalogen contents of the blood samples from patients and from normolipidemic donors were also positively related to the lag time (P<0.005). In vitro loading of LDL with plasmalogen phospholipids resulted in a prolongation of the lag time and an increase in the PC/lysoPC ratio. In conclusion, the rapid rise in LDL contents of plasmalogen phospholipids most probably causes the increase in lag time after LDL apheresis. Plasmalogens appear to play an important role in the oxidation resistance of LDL in vivo.


Key Words: LDL apheresis • plasmalogen phospholipids • lag times • LDL oxidation • lysophosphatidylcholine